Literature DB >> 34022123

Preventing SARS-CoV-2 transmission in the emergency department by implementing a separate pathway for patients with respiratory conditions.

Fulwah Alqahtani1, Marzouqah Alanazi2, Wajdan Alassaf3, Fadilah Sfouq Aleanizy1, Muna Aljahany3, Mercy Joseph4, Mohammad AlRaye4.   

Abstract

OBJECTIVES: This study aimed to describe the development and implementation of a separated pathway to check and treat patients with a suspected/confirmed coronavirus disease 2019 (COVID-19) in the emergency department (ED) at King Abdullah bin Abdulaziz University Hospital in Riyadh.
METHODS: We conducted a retrospective, descriptive longitudinal study from March to July 2020 by analyzing data of all confirmed cases of COVID-19 among ED visitors and healthcare workers in King Abdullah bin Abdulaziz University Hospital.
RESULTS: During the study period, a total of 1,182 swab samples were collected for testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), of which 285 (24.1%) tested positive. Of the 285 cases of confirmed SARS-CoV-2 infection, 18 were healthcare workers and 267 were patients. As a result of using the respiratory pathway for COVID-19 patients, the hospital managed to limit transmission of SARS-CoV-2 not only between patients but also between patients and healthcare workers, while also containing the pandemic. There were no cases of nosocomial SARS-CoV-2 infection recorded among the patients who visited the ED or the flu clinic. All confirmed cases were community acquired and patients were cared for under constrained measures.
CONCLUSIONS: Implementing infection control measures and restricting those with respiratory symptoms to the ED pathway prevented nosocomial spread of SARS-CoV-2 infection in the ED.
© 2021 Fulwah Alqahtani et al., published by De Gruyter, Berlin/Boston.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; emergency department; hospital-acquired infection; infection control

Mesh:

Year:  2021        PMID: 34022123     DOI: 10.1515/jcim-2020-0422

Source DB:  PubMed          Journal:  J Complement Integr Med        ISSN: 1553-3840


  1 in total

Review 1.  FebriDx for rapid screening of patients with suspected COVID-19 upon hospital admission: systematic literature review and meta-analysis.

Authors:  G Lippi; R Nocini; C Mattiuzzi; B M Henry
Journal:  J Hosp Infect       Date:  2022-02-21       Impact factor: 8.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.